Skip to main content
. Author manuscript; available in PMC: 2015 May 4.
Published in final edited form as: Neurobiol Aging. 2014 Mar 11;35(8):1958.e3–1958.e12. doi: 10.1016/j.neurobiolaging.2014.03.005

Table 1.

Demographic characteristics for the DHS-Mind participants

Mean ± SD or % Median (range)
Demographic information
  Age (y) 67.3 ± 8.8 64.4 (41.3–89.2)
  Gender (% female) 55.3%
  BMI (kg/m2) 31.5 ± 6.5 30.4 (17.6–58.4)
  % Smoking (current or past) 55.1%
  Hypertension (%) 78.8%
  Self-reported history of prior CVD 30.9%
Type 2 diabetes
  Type 2 diabetes affected (%) 76.9%
  Diabetes duration (y) 16.6 ± 6.6 14.6 (4.9–44.3)
  Glucose (mg/dL) 134 ± 50 121 (40–349)
  Hemoglobin A1C (%) 7.1 ± 1.3 6.8 (4.9–14.8)
Medication use
  Anti-diabetic medicationa 74.0%
  Cholesterol-lowering medication 67.4%
  Anti-hypertensive medication 81.8%
Education
  Less than high school 18%
  High school 54%
  Greater than high school 28%
Cognitive function test scores
  Modified mini mental state exam (3MSE) 90.4 ± 7.2 92 (43–100)
  Digit symbol substitution (DSST) 47.5 ± 15.3 47 (10–98)
  Stroop 36.2 ± 20.6 30 (−8–161)
  Phonemic fluency 29.8 ± 7.9 28 (2–67)
  Semantic fluency 28.7 ± 11.7 29 (11–60)
  Rey auditory-verbal learning task (RAVLT) 41.6 ± 10.3 42 (11–66)

Key: BMI, body mass index; CVD, cardiovascular disease; DHS, diabetes heart study; SD, standard deviation.

a

Either oral hypoglycemic medications or insulin.